Want to see HYEX full AI Analyst Report?
HYEX Stock Chart & Stats
$1.17
<$0.01(1.01%)
At close: 4:00 PM EDT
$1.17
<$0.01(1.01%)
Day’s Range― - ―
52-Week Range$0.82 - $2.95
Previous CloseN/A
Volume300.00
Average Volume (3M)121.00
Market Cap
$19.02M
Enterprise Value$44.02M
Total Cash (Recent Filing)$189.96K
Total Debt (Recent Filing)$9.07M
Price to Earnings (P/E)―
Beta2.50
Next Earnings
Nov 17, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.16
Shares Outstanding14,741,348
10 Day Avg. Volume42
30 Day Avg. Volume121
Financial Highlights & Ratios
PEG Ratio0.24
Price to Book (P/B)0.59
Price to Sales (P/S)3.13
P/FCF Ratio96.73
Enterprise Value/Market Cap2.31
Enterprise Value/Revenue7.00
Enterprise Value/Gross Profit11.45
Enterprise Value/Ebitda-90.51
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.13
Revenue Forecast (FY)$14.12M
Bulls Say, Bears Say
Bulls Say
Revenue Growth And Gross MarginRevenue growth alongside a strong gross margin indicates improving scale and attractive unit economics in the nutraceutical business. If sustained, this combination can support greater operating leverage, fund product and distribution investment, and strengthen the company’s ability to convert sales expansion into future profitability.
Positive Cash GenerationThe shift to positive operating and free cash flow is a meaningful improvement from negative cash flow in 2021–2023. It suggests better working-capital and expense control, gives the company some internally generated funding for operations, and improves financial resilience as revenue continues to grow.
Improved Equity PositionA stronger equity base and moderate current leverage provide more financial flexibility than the company had in earlier periods. This can help support continued operations and investment while reducing the immediate balance-sheet pressure associated with prior years of substantially higher leverage.
Bears Say
Persistent Operating And Net LossesThe company has not yet translated revenue growth and roughly 61% gross margins into sustainable operating profitability. Continued EBIT and net losses can consume financial resources, limit internally funded investment, and leave results vulnerable if growth slows before sufficient operating leverage is achieved.
Debt Growth And Limited CoverageAlthough current leverage is described as moderate, the sharp increase in debt and low operating-cash-flow coverage reduce financial flexibility. The company therefore depends on continued operational improvement to service obligations and may face greater balance-sheet pressure if costs rise or cash generation weakens.
Governance And Oversight TurnoverA vacant board seat and committee position create a period of governance transition that may weaken oversight continuity. Combined with the stated importance of board committees to long-term operational and financial health, prolonged vacancies could complicate strategic supervision and execution.
Healthy Extracts News
HYEX FAQ
What was Healthy Extracts’s price range in the past 12 months?
Healthy Extracts lowest stock price was $0.82 and its highest was $2.95 in the past 12 months.
What is Healthy Extracts’s market cap?
Healthy Extracts’s market cap is $19.02M.
When is Healthy Extracts’s upcoming earnings report date?
Healthy Extracts’s upcoming earnings report date is Nov 17, 2026 which is in 19 days.
How were Healthy Extracts’s earnings last quarter?
Healthy Extracts released its earnings results on Aug 14, 2026. The company reported -$0.01 earnings per share for the quarter.
Is Healthy Extracts overvalued?
According to Wall Street analysts Healthy Extracts’s price is currently Overvalued.
Does Healthy Extracts pay dividends?
Healthy Extracts does not currently pay dividends.
What is Healthy Extracts’s EPS estimate?
Healthy Extracts’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Healthy Extracts have?
Healthy Extracts has 14,741,348 shares outstanding.
What happened to Healthy Extracts’s price movement after its last earnings report?
Healthy Extracts reported an EPS of -$0.01 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Healthy Extracts?
Currently, no hedge funds are holding shares in HYEX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Healthy Extracts
Healthy Extracts Inc., through its various divisions, specializes in the global and domestic research, development, and sale of natural botanical products. Its portfolio encompasses dietary supplements crafted for cardiovascular wellness, alongside KETONOMICS-branded neuro-enhancers aimed at boosting cognitive functions like memory, mental acuity, concentration, and neural energy. The company further supplies encapsulated bergamot products, available under distinct labels such as BergaMet Pro+, BergaMet Mega+O, BergaMet HERHEART, BergaMet Cholesterol Command, and BergaMet SPORTSHEART. These bergamot offerings are distributed via its online platform and various other channels. Established in 2014 and based in Littleton, Colorado, the company was previously known as Grey Cloak Tech Inc. until its name change in October 2020.
Technical Analysis
Rockwell Med
―
SCYNEXIS
―
Aytu BioScience
―
Cumberland Pharmaceuticals
―
Cosmos Holdings
―
Ownership Overview
77.41%
Insiders
―
Mutual Funds
― Other Institutional Investors
22.59% Public Companies and
Individual Investors